Real-World Effectiveness Study of Nirmatrelvir-Ritonavir or Molnupiravir in Hospitalized Unvaccinated Patients with Chronic Respiratory Diseases and Moderate COVID-19 at Presentation.

Wang Chung KwokTerence Chi Chun TamJames Chung Man HoDavid Chi Leung LamMary Sau-Man IpPak Leung Ho

Published in: International journal of chronic obstructive pulmonary disease (2024)

NMV-r was more effective than MOL among unvaccinated adults with chronic respiratory diseases who were hospitalized for moderate COVID-19 without hypoxaemia on admission.

Keyphrases

coronavirus disease
sars cov
high intensity
randomized controlled trial
emergency department
systematic review
respiratory tract
respiratory syndrome coronavirus